| |
|
|
|
EuroSciCon, Cineworld: The O2, Peninsula Square, London,SE10 0DX, United Kingdom
2nd - 4th June 2014
DAY 1:The 2014 Regenerative Medicine Event: Stem Cell Reprogramming This meeting brings together the principles of engineering and life sciences in tissue development and regenerative medicine to discuss scientific research and developments of clinical applications from leading experts in the field. The newest research and developing technology will be discussed in an informal setting with plenty of networking opportunities. To view the full agenda see: http://lifescienceevents.com/wp-content/uploads/NovelBio4thJune20141.pdf Talks include:
Progressing human pluripotent stem cell technologies for drug discovery and regenerative medicine by genome engineering Dr Peter Sartipy, Cellectis AB, Göteborg, Sweden Chemical Reprogramming of Human Amniotic FLuid Stem Cells to Pluripotency Dr Pascale V Guillot, Senior Lecturer, University College London, UK Cell Sex Matters. It Could Affect Findings Dr Elizabeth Pollitzer, Portia, London, UK Disease modelling in a dish: use of cardiovascular derivatives of human pluripotent stem cells Dr Gabor Foldes, Imperial College London, UK Regulation of human neural stem cell differentiation by noncanonical Wnt signaling Dr Robert Kypta, Group Leader, Center for Cooperative Research in Biosciences (CIC bioGUNE) and Imperial College London, UK
DAY 2:Stem Cells and BioProcessing Harnessing the immense therapeutic and research potential of stem cells requires extensive quality control to ensure the identity, quality, and safety of the cell. Stem cells of different origin and their capability to differentiate towards a specific phenotype as well as tissue engineered constructs are dependent of all kinds of bioprocesses including cultivation media, biomechanical conditions and purification techniques. All topics dealing with the optimization and analysis of processes leading to defined in vitro cultivated cell lines and engineered tissues - with a special focus on bioreactors - will be discussed in this session. To view the pdf agenda please see: http://lifescienceevents.com/wp-content/uploads/3rdJuneStemBiop20141.pdf
Talks include
Proliferation of ASC-derived endothelial cells in a 3D electrospun mesh: Impact of bone-biomimetic nanocomposite and co-culture with ASC-derived osteoblasts. Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland
Bioreactors for tissue engineering
Dr Marianne Ellis, University of Bath, UK
Development of scalable microcarrier-based tissue engineering Dr Ivan Wall, Lecturer in Regenerative Medicine Bioprocessing, University College London, UK
Immune Regulation by Mesenchymal Stromal Cells from Umbilical Cord Dr John Girdlestone, NHS Blood and Transplant, UK
DAY 3: Novel Biomaterials and Technology for use in Regenerative Medicine/Tissue Engineering This meeting brings together the principles of engineering and life sciences in tissue development and regenerative medicine to discuss scientific research and developments of clinical applications from leading experts in the field. The newest research and developing technology will be discussed in an informal setting with plenty of networking opportunities. To view the full agenda click here Talks Include: Functional biomaterials for skeletal tissue engineering Dr Xuebin Yang, Head of Tissue Engineering Research, University of Leeds, UK. Biomaterial is one of the key elements required for tissue engineering. There has been a push in the field of tissue engineering to develop unique biomaterials, or tissue specific scaffolds. Since tissue engineering is a dynamic process, the ideal scaffold should be biocompatible, biodegradable, bioactive and capable of supporting cell attachment, adhesion, proliferation, as well as controlling differentiation, production of extracellular matrix. This will allow tissue to regenerate, remodel and function in a physiological manner. This talk will demonstrate the use of different 3D scaffolds for skeletal tissue engineering both in vitro and in vivo, and discuss the functional elements for the design and fabrication of novel biomaterial scaffolds.
Optimization of a tissue engineered bilayered skin subtitute: striving ofr a positive clinical impact.
Dr François A. Auger, Director of LOEX, Full university professor, Department of Surgery, Université Laval, Québec, QC, Canada
For the treatment of deep or recurring skin wounds, the availability of a skin substitute that includes both dermal and epidermal layers is clinically desirable. The presence of the dermal layer, in addition to reinforcing the fragile cultured epidermis, adds a number of physiological functions to the skin substitute. Clinical data indicates it helps wound healing and reduces scarring. The bilayered skin substitute made at the LOEX is showing much promise for the treatment of burn patients and lower extremity venous and mixed chronic ulcers. A new accelerated production method for this skin substitute is being developed.
Direct cytotoxicity evaluation of biomaterials by micro/nano calorimetry: a new method for materials biocompatibility evaluation
Dr Ali Doostmohammadi, Head of Materials Department, Shahrekord University, Iran
The evaluation of biocompatibility is one of the most important assessments to be performed prior to clinical use of biomaterials. There is a need for a convenient method for screening of biocompatibility and cytotoxicity (as a criterion of biocompatibility), a method that can directly evaluate cell growth as well as cell adhesion to biomaterials surfaces. Isothermal micro-nano calorimetry (IMNC) is capable of measuring the heat production or consumption rate in the microW range with a calorimeter operating at nearly a constant temperature. Therefore, this technique allows direct and continuous monitoring of the metabolic activity of living cells.
A Novel Control Release Platform of Porous PLGA/Gelatin Composite for Fast Induction of Mouse Embryonic Stem Cell Differentiation
Professor Gou-Jen Wang, National Chung-Hsing University, Taiwan
A specifically designed scaffold can enhance the division, proliferation, and differentiation of embryonic stem cell. In this study, various porous PLGA/Gelatin scaffolds coated with mixed solution of gelatin and vascular endothelial cell conditioned medium (ECCM) on the scaffold and pore inner surfaces are proposed. The PLGA/gelatin composited scaffold serves as a control release platform to induce the differentiation of mouse embryonic stem cell into endothelial-like cell. Without any additional growth factor, the starting differentiation time point of mouse embryonic stem cell cultured on the proposed control release scaffolds can be reduced to 1/2 of that of the conventional approaches.
|
|
|
|
|
|
|
|
Organized by:
|
|
Euroscicon |
|
|
Invited Speakers:
|
|
DAY 1:The 2014 Regenerative Medicine Event: Stem Cell Reprogramming Chair: Dr Christopher Ward, Senior Lecturer in Stem Cell Biology, The University ofManchester, UK Speakers: Dr Peter Sartipy, Cellectis AB, Göteborg, Sweden
Dr Pascale V Guillot, Senior Lecturer, University College London, UK
Dr Elizabeth Pollitzer, Portia, London, UK
Dr Gabor Foldes, Imperial College London, UK
Dr Robert Kypta, Group Leader, Center for Cooperative Research in Biosciences (CIC bioGUNE) and Imperial College London, UK
Dr Christopher Ward, Senior Lecturer in Stem Cell Biology, The University of Manchester, UK Dr Kirsten Mcewen, MRC Clinical Sciences Centre, UK Speaker to be confirmed, MTS Cryostores, UK
DAY 2:Stem Cells and BioProcessing Chair: Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland Speakers: Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland
Dr Marianne Ellis, University of Bath, UK Dr Ivan Wall, Lecturer in Regenerative Medicine Bioprocessing, University College London, UK Dr John Girdlestone, NHS Blood and Transplant, UK
Professor Athanasios Mantalaris, Imperial College London, UKDr Farlan Veraitch, Department of Biochemical Engineering, University College London, UK DAY 3: Novel Biomaterials and Technology for use in Regenerative Medicine/Tissue Engineering Chair: Dr Xuebin Yang, Head of Tissue Engineering Research, University of Leeds, UK Speakers: Professor Masaru Tanaka, Department of Biochemical Engineering,Yamagata University, Japan Dr François A. Auger, Director of LOEX, Full university professor, Department of Surgery, Université Laval, Québec, QC, Canada Bose ElectoForce Dr Florelle Gindraux, Université de Franche Comté, France Dr Ali Doostmohammadi, Head of Materials Department, Shahrekord University, Iran Professor Gou-Jen Wang, National Chung-Hsing University, Taiwan Associate Professor Fariba Dehghan, Director of bioengineering and Postgraduate coursework, The University of Sydney, Australia Dr Steve Bloor, Videregen, UK
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
10th March 2014
|
|
|
|
|
|
|
|
Registration:
|
|
Click here to Register
|
|
|
E-mail:
|
|
enquiries@euroscicon.com
|
|
|
|
|
|
|
|
|